Recall: Dr. Reddy's Infusion Bags (Levetiracetram In 0.54% Sodium Chloride Injection)
On 2019-02-04, the FDA announced that Dr. Reddy's Laboratories is conducting a recall on Infusion Bags (Levetiracetram In 0.54% Sodium Chloride Injection) due to a possible lack of proper labeling. The recalled products were sold under the brand name(s) Dr. Reddy's during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 3 drugs recalls due to potential lack of proper labeling, including dyural-40 and dyural-80 convenience kits containing sodium chloride injection, usp, 0.9%, sodium chloride injection, usp, 0.9%, 10 ml fill in a 10 ml vial and more. Additionally, there have been 17 drug and medical device recalls due to other health hazards as well as 77 food recalls.
Company Contact Information:
Name: Dr. Reddy's Laboratories
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.
Product Description: Infusion Bags (Levetiracetram in 0.54% Sodium Chloride Injection)
Brand Name(s): Dr. Reddy's
Reason for Recall: Lack of Proper Labeling
Official Recall Date: 2019-02-04
Additional information provided by the FDA.gov:
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced that it's wholly owned subsidiary, Dr Reddy's Laboratories, Inc is continuing its voluntary nationwide recall of lot ABD807 of Levetiracetram in 0.54% Sodium Chloride Injection, 1,500 mg/100 mL (15 mg/mL) single-dose infusion bags to the hospital level in U.S.A. Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.